Sharecafe

Arovella Therapeutics (ASX: ALA) – Webinar Presentation

Dr Michael Baker - CEO & MD - Arovella develops products and acquires additional platforms that have an impact on the treatment of cancer and conditions that affect the central nervous system.

Dr Michael Baker – CEO & MD – Arovella develops products and acquires additional platforms that have an impact on the treatment of cancer and conditions that affect the central nervous system.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories

Subscribe

get the latest